Lee Scott Golden Sells $634K of PTC Therapeutics Inc (PTCT) — SEC Form 4, Mar 09, 2026
Open-Market Net Sale · SEC Form 4
−$633,800
10b5-1 Plan
Equity position changed by -11.1%
Equity Position
79.9K sh
89,944 → 79,944
Equity Change
-11.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lee Scott Golden CIK 0001686217 |
EVP
|
Lee Scott Golden at PTC Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,081,515
More from this insider at PTC Therapeutics Inc
| 2026-04-06 | Sell | -$56,364 | View |
| 2026-02-20 | Sell | -$172,290 | View |
| 2026-01-12 | Sell | -$66,206 | View |
| 2026-01-08 | Sell | -$152,855 | View |
| 2026-01-06 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-03-05 | S - Sale 10b5-1 | 10,000 D | $63.38 | -$633,800 | 79,944 | Direct |
Footnotes (1)
- F1
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 4, 2025. Show more
Related filings at PTC Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
384
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $1.14B
- Rtw Investments, Lp $632M
- Jupiter Topco Llc $590M
5%+ Holders · 13D/G
5 filers
Other insiders at PTC Therapeutics Inc
-
Michael Schmertzler -$149K
-
Mark Elliott Boulding -$12.3K
-
Michael Schmertzler -$158K
-
Mark Elliott Boulding -$133K
-
Md Steele Glenn Phd Jr -$782K
GET /v1/forms/4/0001686217-26-000010
API docs
View Original SEC Filing